Most GI practitioners say that GLP-1 side effects are the norm, not the exception with 40-70% of GLP-1 patients experiencing GI side effects
While obesity and type 2 diabetes remain strong risk factors, MASLD also affects patients with normal BMI, a phenotype that is especially prevalent in Asian populations and increasingly recognized in broader practice
Theres enough experiential clinical data that Im willing and able to go on record as being bullish about GLP-1 for weight loss
Medication selection is also influenced by budget, insurance coverage, and expected tolerability
I bought this during a late-night desperation scroll, fully expecting to return it
continues to expand its global footprint, exporting its superior leather products to various countries, while maintaining strong relationships with clients worldwide